These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 27841789)

  • 41. The Microbiome in Cystic Fibrosis.
    Huang YJ; LiPuma JJ
    Clin Chest Med; 2016 Mar; 37(1):59-67. PubMed ID: 26857768
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Infections in patients with cystic fibrosis: diagnostic microbiology update.
    Gilligan PH
    Clin Lab Med; 2014 Jun; 34(2):197-217. PubMed ID: 24856524
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The airway microbiome in cystic fibrosis and implications for treatment.
    Zemanick ET; Sagel SD; Harris JK
    Curr Opin Pediatr; 2011 Jun; 23(3):319-24. PubMed ID: 21494150
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical implications of Pseudomonas aeruginosa location in the lungs of patients with cystic fibrosis.
    Moore JE; Mastoridis P
    J Clin Pharm Ther; 2017 Jun; 42(3):259-267. PubMed ID: 28374433
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Changes in lung function in young cystic fibrosis patients between two courses of intravenous antibiotics against Pseudomonas aeruginosa.
    Béghin L; Michaud L; Loeuille GA; Wizla-Derambure N; Sayah H; Sardet A; Thumerelle C; Deschildre A; Turck D; Gottrand F
    Pediatr Pulmonol; 2009 May; 44(5):464-71. PubMed ID: 19360849
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Biosignificance of bacterial cyanogenesis in the CF lung.
    Anderson RD; Roddam LF; Bettiol S; Sanderson K; Reid DW
    J Cyst Fibros; 2010 May; 9(3):158-64. PubMed ID: 20156704
    [TBL] [Abstract][Full Text] [Related]  

  • 47. How can the cystic fibrosis respiratory microbiome influence our clinical decision-making?
    Rogers GB; Bruce KD; Hoffman LR
    Curr Opin Pulm Med; 2017 Nov; 23(6):536-543. PubMed ID: 28786882
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparison of microbiomes from different niches of upper and lower airways in children and adolescents with cystic fibrosis.
    Boutin S; Graeber SY; Weitnauer M; Panitz J; Stahl M; Clausznitzer D; Kaderali L; Einarsson G; Tunney MM; Elborn JS; Mall MA; Dalpke AH
    PLoS One; 2015; 10(1):e0116029. PubMed ID: 25629612
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The Evolving Cystic Fibrosis Microbiome: A Comparative Cohort Study Spanning 16 Years.
    Acosta N; Whelan FJ; Somayaji R; Poonja A; Surette MG; Rabin HR; Parkins MD
    Ann Am Thorac Soc; 2017 Aug; 14(8):1288-1297. PubMed ID: 28541746
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Bronchial Epithelial Cells from Cystic Fibrosis Patients Express a Specific Long Non-coding RNA Signature upon
    Balloy V; Koshy R; Perra L; Corvol H; Chignard M; Guillot L; Scaria V
    Front Cell Infect Microbiol; 2017; 7():218. PubMed ID: 28611953
    [No Abstract]   [Full Text] [Related]  

  • 51. Cystic Fibrosis Rapid Response: Translating Multi-omics Data into Clinically Relevant Information.
    Cobián Güemes AG; Lim YW; Quinn RA; Conrad DJ; Benler S; Maughan H; Edwards R; Brettin T; Cantú VA; Cuevas D; Hamidi R; Dorrestein P; Rohwer F
    mBio; 2019 Apr; 10(2):. PubMed ID: 30992350
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Insights into the respiratory tract microbiota of patients with cystic fibrosis during early Pseudomonas aeruginosa colonization.
    Keravec M; Mounier J; Prestat E; Vallet S; Jansson JK; Burgaud G; Rosec S; Gouriou S; Rault G; Coton E; Barbier G; Héry-Arnaud G
    Springerplus; 2015; 4():405. PubMed ID: 26266076
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pseudomonas aeruginosa, cyanide accumulation and lung function in CF and non-CF bronchiectasis patients.
    Ryall B; Davies JC; Wilson R; Shoemark A; Williams HD
    Eur Respir J; 2008 Sep; 32(3):740-7. PubMed ID: 18480102
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Lung Microbiota Changes Associated with Chronic Pseudomonas aeruginosa Lung Infection and the Impact of Intravenous Colistimethate Sodium.
    Collie D; Glendinning L; Govan J; Wright S; Thornton E; Tennant P; Doherty C; McLachlan G
    PLoS One; 2015; 10(11):e0142097. PubMed ID: 26544950
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pathophysiology and management of pulmonary infections in cystic fibrosis.
    Gibson RL; Burns JL; Ramsey BW
    Am J Respir Crit Care Med; 2003 Oct; 168(8):918-51. PubMed ID: 14555458
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The altered gut microbiota in adults with cystic fibrosis.
    Burke DG; Fouhy F; Harrison MJ; Rea MC; Cotter PD; O'Sullivan O; Stanton C; Hill C; Shanahan F; Plant BJ; Ross RP
    BMC Microbiol; 2017 Mar; 17(1):58. PubMed ID: 28279152
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Respiratory bacterial infections in cystic fibrosis.
    Ciofu O; Hansen CR; Høiby N
    Curr Opin Pulm Med; 2013 May; 19(3):251-8. PubMed ID: 23449384
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Microbiology of Cystic Fibrosis Airway Disease.
    Blanchard AC; Waters VJ
    Semin Respir Crit Care Med; 2019 Dec; 40(6):727-736. PubMed ID: 31887768
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Longitudinal development of mucoid Pseudomonas aeruginosa infection and lung disease progression in children with cystic fibrosis.
    Li Z; Kosorok MR; Farrell PM; Laxova A; West SE; Green CG; Collins J; Rock MJ; Splaingard ML
    JAMA; 2005 Feb; 293(5):581-8. PubMed ID: 15687313
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Respiratory mycobiome and suggestion of inter-kingdom network during acute pulmonary exacerbation in cystic fibrosis.
    Soret P; Vandenborght LE; Francis F; Coron N; Enaud R; Avalos M; Schaeverbeke T; Berger P; Fayon M; Thiebaut R; Delhaes L;
    Sci Rep; 2020 Feb; 10(1):3589. PubMed ID: 32108159
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.